- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Confo Therapeutics secures €60m funds to progress GPCR-modulating therapies | ||
| Do | Oisín secures funds to advance treatments for age-related ailments | ||
| Mi | FDA grants RMAT designation to AffyImmune's AIC100 for thyroid cancer | ||
| Di | Vividion Therapeutics to expand capabilities with new R&D centre in US | ||
| Mo | Apollo Therapeutics and University of Oxford sign drug discovery partnership | ||
| 19.07. | Diamyd Medical secures FDA fast track status for type 1 diabetes treatment | ||
| 18.07. | Lynch Regenerative Medicine secures funds to develop skin regeneration solutions | ||
| 17.07. | Merck KGaA launches GMP-compliant cell culture media line in China | ||
| 16.07. | US FDA grants RMAT designation for Kyverna's KYV-101 | ||
| 15.07. | Merck enhances ophthalmology portfolio with EyeBio acquisition | ||
| 12.07. | Leqembi gains approval for Alzheimer's treatment in Israel | ||
| 11.07. | Cosette Pharmaceuticals acquires Ambien rights in US | ||
| 10.07. | Amneal Pharmaceuticals launches ready-to-use injectable FOCINVEZ | ||
| 09.07. | Adicet Bio's ADI-270 receives FDA Fast Track Designation for kidney cancer treatment | ||
| 08.07. | EU approves AstraZeneca's Tagrisso combined with chemotherapy for EGFRm NSCLC | ||
| 05.07. | Alembic receives tentative approval from USFDA for Ivosidenib Tablets | ||
| 04.07. | Beacon Therapeutics secures $170m to expedite gene therapy development | ||
| 03.07. | FDA grants fast track status for Full-Life's prostate cancer treatment | ||
| 02.07. | Signet Therapeutics receives FDA approval for sigx1094 IND application | ||
| 01.07. | EMA CHMP recommends marketing authorisation for Moderna's RSV vaccine | ||
| 28.06. | FDA grants Fast Track designation to Tubulis' TUB-040 for ovarian cancer treatment | ||
| 27.06. | FDA approves Verona Pharma's Ohtuvayre for COPD treatment | ||
| 26.06. | Augustine raises €17m to advance lead candidate into trials for neuro conditions | ||
| 25.06. | Takeda's LIVTENCITY receives approval in Japan for CMV infections | ||
| 24.06. | Juniper Biologics to distribute Caris Life Sciences' molecular profiling services in MEA |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
